1. Development and evaluation of a disulfidoptosis-related lncRNA index for prognostication in clear cell renal cell carcinoma
- Author
-
Renhui Guan, You Zuo, Qinglong Du, Aijing Zhang, Yijian Wu, Jianguo Zheng, Tongrui Shi, Lin Wang, Hui Wang, and Nengwang Yu
- Subjects
Clear cell renal cell carcinoma ,Single-cell deconvolution ,Disulfidoptosis ,Long non-coding RNA ,Prognostic index ,Tumor microenvironmen ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Background: This study introduces a novel prognostic tool, the Disulfidoptosis-Related lncRNA Index (DRLI), integrating the molecular signatures of disulfidoptosis and long non-coding RNAs (lncRNAs) with the cellular heterogeneity of the tumor microenvironment, to predict clinical outcomes in patients with clear cell renal cell carcinoma (ccRCC). Methods: We analyzed 530 tumor and 72 normal samples from The Cancer Genome Atlas (TCGA), employing k-means clustering based on disulfidoptosis-associated gene expression to stratify ccRCC samples into prognostic groups. lncRNAs correlated with disulfidoptosis were identified and used to construct the DRLI, which was validated by Kaplan-Meier and receiver operating characteristic curves. We utilized single-cell deconvolution analysis to estimate the proportion of immune cell types within the tumor microenvironment, while the ESTIMATE and TIDE algorithms were employed to assess immune infiltration and potential response to immunotherapy. Results: The Disulfidoptosis-Related lncRNA Index (DRLI) effectively stratified ccRCC patients into high and low-risk groups, significantly impacting survival outcomes (P
- Published
- 2024
- Full Text
- View/download PDF